TGN-208

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTGN-208
Drug Alias NamesiRNA nanoparticle natriuretic peptide receptor A expression inhibitor (Transgenex Nanobiotech)TGN-208
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionNatriuretic peptide receptor 1 inhibitors
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransGenex Nanobiotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransGenex Nanobiotech Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A